From: Patan hospital experience in treating philadelphia chromosome/BCR-ABL1 positive chronic myeloid leukemia patients with gleevec (imatinib mesylate); the first generation specific tyrosine kinase inhibitor
Medication Use at Presentation
Medications
No
Hydroxycarbamide
61
Busulfan
1
Imatinib
Hydroxycarbamide+Imatinib
Hydroxycarbamide+Busulfan
No anticancer drugs
41
Total
106